Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Fundamentals

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
SHARE INFORMATION
Market Cap$ 10,564,071,352
Shares Outstanding71,494,798
Float64,590,849
Percent Float90.34%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 462,509,000
Latest Fiscal EPS$ -13.13
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions689
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months9,045,854
Institutional Holdings Percent151.7%
Institutional Sold Previous 3 Months27,664,486
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months7,320
Insider Holdings Percent9.2
Insider Sold Previous 3 Months6,450
Insider Shares Owned6,554,839
TRADING INFO
52 Week High$ 151.51
52 Week Low$ 79.01
52 Week High Change$ 30.82
21 Day Moving Average$ 146.4729
21 Day Extended Moving Average$ 146.4568
50 Day Moving Average$ 145.5796
50 Day Extended Moving Average$ 143.2102
200 Day Moving Average$ 128.486
200 Day Extended Moving Average$ 129.5379
10 Day Average Volume523,363
20 Day Average Volume549,748
30 Day Average Volume635,724
50 Day Average Volume762,143
Alpha0.033124
Beta1.0276
Standard Deviation0.174053
R20.087194
7 Day Price Change$ 0.78
7 Day Percent Change0.53%
21 Day Price Change$ 1.81
21 Day Percent Change1.24%
30 Day Price Change$ 2.76
30 Day Percent Change1.9%
Month to Date Price Change$ 1.74
Month to Date Percent Change1.19%
Quarter to Date Price Change$ 2.05
Quarter to Date Percent Change1.41%
180 Day Price Change$ 12.92
180 Day Percent Change9.58%
200 Day Price Change$ 28.99
200 Day Percent Change24.41%
Year to Date Price Change$ 9.95
Year to Date Percent Change7.22%

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Key Ratios

PROFITABILITY
EBIT Margin-87.1%
EBITDA Margin-84.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count-77.63%
Gross Margin85.6%
Profit Margin TOT-77.63%
INCOME STATEMENTS
Revenue$ 859,684,000
Revenue Per Share$ 12.0244
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-13.20
Total Debt To Equity0.00
Int Coverage-4.70
Current Ratio1.70
Leverage Ratio-1.90
Quick Ratio1.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-10.00
Enterprise Value$ 10,764,844,132
Price to Sales12.2883
Price to Free Cash-17.20
PE High Last 5 Years-8.50
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years-5.50
Price to Tangible Book-13.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.00
Invoice Turnover1.40
Assets Turnover0.40
Return Assets-91.52
Return on Equity162.81
Return on Capital-751.37

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOVlad Coric
Emplyoees928
Last AuditUQ
CIK0001689813
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressC/o Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven, CT 6510
Websitehttps://www.biohavenpharma.com
Facsimile-
Telephone+1 203 404-0410
EmailVlad.Coric@biohavenpharma.com


Your Recent History
NYSE
BHVN
Biohaven P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.